HPCwire

Leading HPC
Solution Providers




















HPCwire >> Industry >> Financial Services

Gene Network Sciences Creates Quant Finance Spin-Off


CAMBRIDGE, Mass., Nov. 25 -- Gene Network Sciences, Inc. (GNS) today announced that it has created a subsidiary company, Fina Technologies, Inc. (Fina) to leverage its proprietary Reverse Engineering, Forward Simulation (REFS) software platform in a new arena -- that of quantitative financial trading and e-commerce. REFS was originally developed to rapidly process raw clinical and genomics data to identify drug targets, biomarkers and drug and disease mechanisms for disease categories such as cancer, diabetes and inflammation, and has been used by GNS in partnership with leading pharmaceutical companies and clinical research organizations such as Johnson & Johnson, Pfizer, Novartis AG, Biogen Idec, UCSF Cancer Center, and Jackson Laboratories for these purposes.

"Hidden complex networks govern everything from human diseases to financial markets and the internet, making reliable predictions impossible," said Colin Hill, President and CEO of GNS and Chairman of the Board of Fina: "It is only today that terabytes of data, on-demand supercomputing, and next-generation artificial intelligence software have converged to enable the uncovering of such networks, and prediction of their behavior, such as predicting how a combination of two cancer drugs would affect the size of a tumor in a cancer patient with a particular DNA sequence."

GNS, who developed their proprietary REFS technology over the past eight years, uses supercomputers to rapidly accelerate the processing of raw data into meaningful biomedical outcomes. To date, this REFS software has been used to probe and analyze how genes and proteins interconnect in a complex web with the goal of developing better drugs. Today, GNS has launched Fina Technolgies (http://www.finatechnologies.com) to monetize their REFS technology in the e-commerce and financial trading markets, while remaining focused on their original drug development mission.

Fina Technologies has obtained from GNS an exclusive license to certain non-biological applications of REFS, such as quantitative finance, e-commerce, insurance, and fraud detection. "Fina will use REFS to create quantitative trading algorithms and deliver business solutions for a new class of data intensive problems," said Josh Holden, CEO of Fina. "After spending 13 years trading on Wall Street, this is the first tool I've seen that automates the discovery of complex and evolving relationships from massive amounts of data, leading to more reliable and more profitable trading strategies."

Fina Technologies is supported in their efforts through an initial round of investment led by Reed Elsevier Ventures, the venture arm of the multibillion dollar Anglo-Dutch media conglomerate Reed Elsevier, owner of such assets as Lexis-Nexis, and by a Board of Directors steeped in finance and e-commerce. In addition to Colin Hill, Co-founder and President and CEO of GNS, the Board of Fina includes Bill Trenchard, founder of Jump Networks, a start-up company that developed the world's first online calendaring system, which was sold to Microsoft for $50 million in 1999, and who is a current Board member of LiveOps, another company he founded. Also on the Board of Fina are Kevin Brown, Partner at Reed Elsevier Ventures; and Robert Maroney, Investment Manager at Connecticut Investments, LLC.

About REFS

Reverse Engineering/Forward Simulation (REFS) is a technology that systematically turns multiple layers of data into an unprecedented view of complex systems as a "whole," without requiring previous knowledge of the structure of the system. REFS begins with raw data and rapidly performs billions upon billions of calculations using supercomputers to determine how the individual components in the system interact with one another (Reverse Engineering). These computer-assembled models are then simulated using billions of in silico queries (Forward Simulation) to discover the highest-impact components and to predict outcomes for previously unseen scenarios.

About Gene Network Sciences

Founded in 2000, Gene Network Sciences (http://www.gnsbiotech.com) is a leader in biosimulation with its ability to derive molecular mechanisms of drugs and diseases directly from molecular profiling and clinical data without any a priori knowledge. Headquartered in Cambridge, Massachusetts, GNS uses its REFS (reverse engineering and forward simulation) technology in pharmaceutical and clinical settings to rapidly turn complex and heterogeneous data sets into cell and organ-level computer models of disease biology, drug efficacy and drug safety. These models simulate mechanisms of disease and the clinical performance of drug candidates. By discovering how and why specific drug candidates impact human biology, GNS technology enables the rapid development of breakthrough drug and diagnostic products.

-----

Source: Gene Network Sciences



Article Tools

  • Print This Page
  • Bookmark This Article

Share Options

(Digg, Technorati, more)


Subscribe

Discussion

There are 0 discussion items posted.  

Sponsored Links

New Paper: Parallel Computing Without Parallel Programming
Learn how domain experts can run VHLL programs like MATLAB® on a variety of high-performance platforms without low-level reprogramming and how to work with the largest datasets and complex algorithms without sacrificing ease of use or reducing productivity.



Feature Articles

Spider Up and Spinning Connections to All Computing Platforms at ORNL

Spider, the world's biggest Lustre-based, centerwide file system, has been fully tested to support Oak Ridge National Laboratory's new petascale Cray XT4/XT5 Jaguar supercomputer and is now offering early access to scientists.
Read More...

Wolfram Alpha: A Web-Based Application That Embraced Supercomputers

Wolfram Alpha, the Web-based computational engine introduced in May, is not a traditional supercomputing application, but relies on supercomputers to satisfy its unique requirements.
Read More...

TeraGrid '09: Student Participation Soars

There was a new energy at this year's TeraGrid '09 conference thanks to an outstanding turnout for the student program. Thanks to support from the National Science Foundation, more than 100 high school, undergraduate and graduate students were able to participate in the conference.
Read More...

Top Headlines

3D Seismic Data: Taking a Smarter Approach to Interpretation

Jul 09 | Engineer Live | The demand for computational tools to underpin the 3D seismic interpretation process has never been more apparent. Read more...

Engineering Unemployment Soared in 2Q to 8.6%

Jul 08 | EE Times | Unemployment for U.S. engineers has reached record levels, according to government figures. Read more...

Gartner Adjusts 2009 IT Spend Downward Again

Jul 08 | Network World | Global spending for 2009 projected to drop 6 percent, for a total of $3.2 trillion. Read more...

Concurrent and Parallel Are Not The Same

Jul 08 | Linux Magazine | Portability or efficiency? Neither is guaranteed when writing explicit parallel code. Read more...

800 TFLOP Real-Time Ray Tracing GPU Unveiled, Not for Gamers

Jul 07 | Ars Technica | Japanese company builds custom ASIC to accelerate real-time ray traced rendering for the auto industry. Read more...

Featured Whitepapers

Parallel Computing Without Parallel Programming

Jul 10 | | Engineers, scientists, and other domain experts depend on the productivity enabled by very high-level language (VHLL) tools like MATLAB® and Python. However, as datasets grow larger and programs get more sophisticated, ordinary desktop computers can no longer keep up. The paper explores how to run VHLL programs on high-performance platforms without low-level reprogramming. Work with large datasets and complex algorithms without sacrificing ease of use or reducing productivity.

Building High Performance Computing in a Green and Modular Solution Building Block

Apr 14 | | Many HPC IT departments are feeling the rising pressure to deliver more capacity computing and performance while trying to reduce the total cost of ownership. This white paper discusses how an environmentally-friendly and open-standards HPC building block based computing system using flexible interconnect options helps address capacity computing needs.

Multimedia

Webcast: Dell Expands HPC Access and Adoption with Intel Cluster Ready Program


Source: Addison Snell, GM/VP, Tabor Research; sponsored by Dell

Many organizations that could benefit from the use of HPC clusters find that it is complicated to get the systems up and running because of limited IT resources or the complexities of the clusters themselves. Learn how the Intel Cluster Ready program, for which Dell was an original partner, seeks to address this challenge for entry level and mid-range HPC users.

Video White Paper: Architecting a Better Network Storage Solution

BlueArc's Titan architecture represents an evolutionary step in file servers by creating a hardware-based file system that can scale bandwidth, IOPS, and overall data capacity well beyond conventional software-based devices. With its ability to virtualize a massive storage pool of up to four usable petabytes of tiered storage, Titan can scale with growing data requirements, offering a competitive advantage for businesses, researchers, or other enterprises seeking to better manage data growth while still ensuring optimal performance.

Webcast: HPC Development Solutions: Sun Studio & Sun HPC ClusterTools


Sun Studio Compilers and Tools and Sun HPC ClusterTools allow you to create high performance parallel applications for OpenSolaris, Solaris and Linux. Sun Studio Express 11/08 includes MPI performance analysis capabilities and full OpenMP 3.0 compiler support. Learn about all this and the latest in Sun HPC ClusterTools 8.1.

Special Feature: ISC'09

Newsletters

Stay informed! Subscribe to HPCwire email Newsletters.






HPC Job Bank


Featured Events

WORLDCOMP 2009
Data Mining Courses